JAGLX Holdings — Janus Henderson Global Life Sciences Fund
All 104 reported holdings of Janus Henderson Global Life Sciences Fund (JAGLX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co. | 8.84% | $459.41M |
| Johnson & Johnson | 7.29% | $378.94M |
| AstraZeneca PLC | 4.59% | $238.63M |
| AbbVie Inc. | 4.05% | $210.53M |
| UnitedHealth Group Inc. | 3.13% | $162.69M |
| Novartis AG | 2.86% | $148.41M |
| Thermo Fisher Scientific Inc | 2.51% | $130.39M |
| Praxis Precision Medicines Inc | 2.45% | $127.26M |
| Argenx SE | 2.40% | $124.75M |
| Abbott Laboratories | 2.40% | $124.49M |
| Bridgebio Pharma Inc | 2.22% | $115.19M |
| Roche Holding AG | 2.21% | $114.90M |
| Sanofi SA | 2.07% | $107.72M |
| Vertex Pharmaceuticals Incorporated | 2.06% | $107.13M |
| Revolution Medicines Inc | 2.04% | $105.81M |
| Intuitive Surgical Inc. | 2.02% | $104.79M |
| HCA Healthcare Inc | 1.88% | $97.77M |
| Boston Scientific Corporation | 1.84% | $95.39M |
| Amgen Inc. | 1.83% | $95.03M |
| Ascendis Pharma A/S | 1.65% | $85.82M |
| Stryker Corporation | 1.65% | $85.71M |
| Danaher Corporation | 1.64% | $85.05M |
| Madrigal Pharmaceuticals Inc | 1.50% | $78.10M |
| CVS Health Corp | 1.48% | $76.98M |
| Merck & Co., Inc | 1.48% | $76.81M |
| PTC Therapeutics, Inc. | 1.34% | $69.78M |
| United Therapeutics Corporation | 1.33% | $69.21M |
| Mckesson Corp. | 1.33% | $69.07M |
| Gilead Sciences Inc. | 1.26% | $65.74M |
| Globus Med Inc | 1.24% | $64.50M |
| Mirum Pharmaceuticals Inc. | 1.22% | $63.32M |
| Teva Pharmaceutical Industries Ltd. | 1.18% | $61.37M |
| Vaxcyte Inc | 1.09% | $56.47M |
| Medtronic PLC | 0.97% | $50.55M |
| Elevance Health Inc. | 0.93% | $48.39M |
| Dyne Therapeutics Inc. | 0.88% | $45.84M |
| Cencora Inc | 0.84% | $43.71M |
| Travere Therapeutics Inc | 0.82% | $42.55M |
| Lantheus Holdings Inc | 0.76% | $39.35M |
| Medline Inc. | 0.74% | $38.47M |
| Edwards Lifesciences Corporation | 0.72% | $37.28M |
| DexCom Inc | 0.68% | $35.26M |
| Soleno Therapeutics Inc | 0.64% | $33.07M |
| Apogee Therapeutics Inc. | 0.61% | $31.95M |
| Ucb SA | 0.61% | $31.49M |
| Becton, Dickinson and Company | 0.55% | $28.55M |
| Glaukos Corp. | 0.55% | $28.50M |
| Structure Therapeutics Inc | 0.53% | $27.45M |
| IDEAYA Biosciences Inc. | 0.47% | $24.62M |
| Penumbra Inc. | 0.47% | $24.21M |
| Tarsus Pharmaceuticals Inc | 0.40% | $20.79M |
| Edgewise Therapeutics Inc. | 0.40% | $20.77M |
| Xenon Pharmaceuticals Inc | 0.39% | $20.27M |
| Janus Henderson Cash Liquidity Fund LLC | 0.39% | $20.15M |
| The Cooper Companies, Inc. | 0.39% | $20.14M |
| Cogent Biosciences Inc. | 0.37% | $19.19M |
| Biohaven Ltd | 0.36% | $18.78M |
| Regeneron Pharmaceuticals, Inc. | 0.36% | $18.54M |
| Daiichi Sankyo Co Ltd. | 0.36% | $18.46M |
| Steris PLC | 0.35% | $18.11M |
| Neurocrine Biosciences Inc | 0.35% | $18.04M |
| Protagonist Therapeutics Inc | 0.33% | $16.90M |
| Scholar Rock Holding Corp. | 0.32% | $16.80M |
| Zoetis Inc. | 0.30% | $15.60M |
| Ardelyx Inc | 0.30% | $15.55M |
| Alnylam Pharmaceuticals Inc. | 0.29% | $15.22M |
| Sotera Health Company | 0.29% | $15.17M |
| Crinetics Pharmaceuticals Inc. | 0.28% | $14.32M |
| HeartFlow Inc. | 0.27% | $14.25M |
| Rhythm Pharmaceuticals Inc | 0.27% | $13.99M |
| Nuvalent Inc | 0.25% | $13.15M |
| Illumina Inc | 0.24% | $12.60M |
| Insulet Corporation | 0.24% | $12.43M |
| Kardium Series 8 Class D Preferred Shares USD | 0.24% | $12.24M |
| Teleflex Incorporated | 0.23% | $11.72M |
| Mirum Pharmaceuticals Inc | 0.22% | $11.43M |
| Centene Corp. | 0.21% | $11.16M |
| Janux Therapeutics Inc | 0.19% | $10.01M |
| Olema Pharmaceuticals Inc. | 0.19% | $9.98M |
| Terns Pharmaceuticals Inc. | 0.19% | $9.86M |
| Humana Inc. | 0.18% | $9.14M |
| Immunome Inc | 0.16% | $8.06M |
| 4D Molecular Therapeutics Inc | 0.15% | $7.86M |
| Green Cross Holdings Corp | 0.10% | $5.33M |
| Lexeo Therapeutics Inc | 0.07% | $3.64M |
| Loadsmart Inc | 0.07% | $3.54M |
| Magnolia Medical Technologies | 0.05% | $2.57M |
| Element Biosciences Inc | 0.05% | $2.46M |
| Green Cross Holdings Corp | 0.04% | $2.33M |
| Pfizer, Inc. | 0.04% | $1.92M |
| Twinstrand Biosciences Inc | 0.03% | $1.38M |
| Freenome Holdings Inc | 0.02% | $1.02M |
| Freenome Holdings Inc | 0.02% | $997.91K |
| Sonoma Biotherapeutics Inc | 0.02% | $985.33K |
| Asher Biotherapeutics Inc | 0.02% | $809.96K |
| Sonoma Biotherapeutics Inc | 0.01% | $525.50K |
| Attralus Inc | 0.01% | $415.36K |
| Asher Biotherapeutics Inc | 0.01% | $381.11K |
| Novo Nordisk A/S | 0.01% | $370.03K |
| Hemoshear Therapeutics LLC | 0.01% | $350.03K |
| Alkermes PLC | 0.01% | $288.13K |
| Japan Yen Cash Balance | 0.00% | $21.34K |
| Euro Member Countries Cash Balance | 0.00% | $287 |
| Magnolia Medical Technologies | 0.00% | $0 |
JAGLX overview: performance, fees, allocation and SEC filings